Related Experiment Video
Updated: Feb 24, 2026
06:23
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
8.5K
[Amyloid neuropathy resulting from an unknown protein]
R Younsi1, N Birouk, N Kissani
1Service de rhumatologie, Centre Hospitalo-Universitaire Mohammed-VI, B.P. 2659, 4000 Marrakech, Maroc. younsirachid1@yahoo.fr
La Revue De Medecine Interne
|July 1, 2008
Summary
This study identifies a rare peripheral neuropathy case unrelated to transthyretin amyloidosis. Mass spectrometry shows promise for diagnosing this uncommon form of amyloid neuropathy.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Amyloid neuropathy encompasses acquired and hereditary forms, often linked to transthyretin (TTR) variants.
- Transthyretin amyloidosis is a progressive condition affecting peripheral nerves.
Observation:
- A 42-year-old male presented with peripheral neuropathy.
- The patient's condition was not associated with known transthyretin mutations.
Findings:
- The neuropathy was identified as a rare form of amyloidosis.
- Mass spectrometry proved instrumental in characterizing the amyloid deposits.
Implications:
- This case highlights the existence of non-TTR related amyloid neuropathies.
- Mass spectrometry offers a valuable diagnostic tool for rare amyloidosis subtypes.
- Further research is needed to understand the etiology and management of these rare conditions.
Related Concept Videos
03:03Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
03:03Amyloid Fibrils
6.8K
No description available
6.8K
01:26Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
01:21Overview of Protein Metabolism
4.2K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.2K